Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för David H Persing. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att David H Persing har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:CPHD / Cepheid | EVP, Chief Med/Tech Officer, Director | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av David H Persing. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av David H Persing som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2016-11-07 |
|
4 | CPHD |
CEPHEID
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | −50 500 | 0 | −100,00 | ||||
2016-11-07 |
|
4 | CPHD |
CEPHEID
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | −56 250 | 0 | −100,00 | ||||
2016-11-07 |
|
4 | CPHD |
CEPHEID
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | −41 250 | 0 | −100,00 | ||||
2016-11-07 |
|
4 | CPHD |
CEPHEID
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | −52 500 | 0 | −100,00 | ||||
2016-11-07 |
|
4 | CPHD |
CEPHEID
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | −48 750 | 0 | −100,00 | ||||
2016-11-07 |
|
4 | CPHD |
CEPHEID
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | −48 750 | 0 | −100,00 | ||||
2016-11-07 |
|
4 | CPHD |
CEPHEID
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | −43 500 | 0 | −100,00 | ||||
2016-11-07 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
D - Sale to Issuer | −2 420 | 0 | −100,00 | ||||
2016-11-07 |
|
4 | CPHD |
CEPHEID
Performance Stock Unit |
D - Sale to Issuer | −25 250 | 0 | −100,00 | ||||
2016-11-07 |
|
4 | CPHD |
CEPHEID
Common Stock |
D - Sale to Issuer | −14 430 | 0 | −100,00 | ||||
2016-10-31 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −365 | 732 | −33,27 | ||||
2016-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −138 | 14 430 | −0,95 | 52,76 | −7 281 | 761 327 | |
2016-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 365 | 14 568 | 2,57 | ||||
2016-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −147 | 14 203 | −1,02 | 52,92 | −7 779 | 751 623 | |
2016-10-24 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −281 | 1 688 | −14,27 | ||||
2016-10-24 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −106 | 14 350 | −0,73 | 52,80 | −5 597 | 757 680 | |
2016-10-24 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 281 | 14 456 | 1,98 | ||||
2016-08-02 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −366 | 1 097 | −25,02 | ||||
2016-08-02 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −138 | 14 175 | −0,96 | 35,33 | −4 876 | 500 803 | |
2016-08-02 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 366 | 14 313 | 2,62 | ||||
2016-07-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −147 | 14 047 | −1,04 | 33,10 | −4 866 | 464 956 | |
2016-07-28 |
|
4 | CPHD |
CEPHEID
Performance Stock Unit |
A - Award | 25 250 | 25 250 | |||||
2016-07-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −281 | 1 969 | −12,49 | ||||
2016-07-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −106 | 14 194 | −0,74 | 32,90 | −3 487 | 466 983 | |
2016-07-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 281 | 14 300 | 2,00 | ||||
2016-05-03 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −365 | 1 463 | −19,97 | ||||
2016-05-03 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −138 | 14 019 | −0,97 | 28,54 | −3 939 | 400 102 | |
2016-05-03 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 365 | 14 157 | 2,65 | ||||
2016-04-29 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −588 | 13 792 | −4,09 | 36,57 | −21 503 | 504 373 | |
2016-04-27 |
|
4 | CPHD |
CEPHEID
Employee Stock Option (Right to Buy) |
A - Award | 50 500 | 50 500 | |||||
2016-04-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −339 | 0 | −100,00 | ||||
2016-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −128 | 14 380 | −0,88 | 35,34 | −4 524 | 508 189 | |
2016-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 339 | 14 508 | 2,39 | ||||
2016-04-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −282 | 2 250 | −11,14 | ||||
2016-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −106 | 14 169 | −0,74 | 34,98 | −3 708 | 495 632 | |
2016-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 282 | 14 275 | 2,02 | ||||
2016-02-02 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −366 | 1 828 | −16,68 | ||||
2016-02-02 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −161 | 13 993 | −1,14 | 29,45 | −4 741 | 412 094 | |
2016-02-02 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 366 | 14 154 | 2,65 | ||||
2016-01-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −338 | 339 | −49,93 | ||||
2016-01-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −148 | 13 788 | −1,06 | 32,93 | −4 874 | 454 039 | |
2016-01-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 338 | 13 936 | 2,49 | ||||
2016-01-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −281 | 2 532 | −9,99 | ||||
2016-01-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −124 | 13 598 | −0,90 | 32,68 | −4 052 | 444 383 | |
2016-01-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 281 | 13 722 | 2,09 | ||||
2015-11-02 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −366 | 2 194 | −14,30 | ||||
2015-11-02 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −189 | 13 441 | −1,39 | 34,27 | −6 477 | 460 623 | |
2015-11-02 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 366 | 13 630 | 2,76 | ||||
2015-10-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −339 | 677 | −33,37 | ||||
2015-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −128 | 13 264 | −0,96 | 30,87 | −3 951 | 409 460 | |
2015-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 339 | 13 392 | 2,60 | ||||
2015-10-23 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −281 | 2 813 | −9,08 | ||||
2015-10-23 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −106 | 13 053 | −0,81 | 30,02 | −3 182 | 391 851 | |
2015-10-23 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 281 | 13 159 | 2,18 | ||||
2015-07-31 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −365 | 2 560 | −12,48 | ||||
2015-07-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −138 | 12 878 | −1,06 | 55,71 | −7 688 | 717 433 | |
2015-07-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 365 | 13 016 | 2,89 | ||||
2015-07-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −338 | 1 016 | −24,96 | ||||
2015-07-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −128 | 12 651 | −1,00 | 56,26 | −7 201 | 711 745 | |
2015-07-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 338 | 12 779 | 2,72 | ||||
2015-07-23 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −281 | 3 094 | −8,33 | ||||
2015-07-23 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −106 | 12 441 | −0,84 | 62,93 | −6 671 | 782 912 | |
2015-07-23 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 281 | 12 547 | 2,29 | ||||
2015-05-01 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −366 | 2 925 | −11,12 | ||||
2015-05-01 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −138 | 12 266 | −1,11 | 56,71 | −7 826 | 695 605 | |
2015-05-01 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 366 | 12 404 | 3,04 | ||||
2015-04-28 |
|
4 | CPHD |
CEPHEID
Non-qualified option (Right to Buy) |
A - Award | 56 250 | 56 250 | |||||
2015-04-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
A - Award | 6 250 | 12 038 | 107,98 | ||||
2015-04-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −302 | 0 | −100,00 | ||||
2015-04-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −114 | 5 788 | −1,93 | 58,97 | −6 723 | 341 318 | |
2015-04-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 302 | 5 902 | 5,39 | ||||
2015-04-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −339 | 1 354 | −20,02 | ||||
2015-04-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −128 | 5 600 | −2,23 | 58,97 | −7 548 | 330 232 | |
2015-04-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 339 | 5 728 | 6,29 | ||||
2015-04-23 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −1 125 | 3 375 | −25,00 | ||||
2015-04-23 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −423 | 5 389 | −7,28 | 53,92 | −22 808 | 290 575 | |
2015-04-23 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 125 | 5 812 | 24,00 | ||||
2015-02-24 |
|
4 | CPHD |
CEPHEID
Non-qualified Stock Option (Right to Buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2015-02-24 |
|
4 | CPHD |
CEPHEID
Non-qualified Stock Option (Right to Buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2015-02-24 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | −5 000 | 4 687 | −51,62 | 58,60 | −293 011 | 274 669 | |
2015-02-24 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | −5 000 | 4 687 | −51,62 | 58,60 | −293 011 | 274 669 | |
2015-02-24 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 5 000 | 9 687 | 106,68 | 7,38 | 36 900 | 71 490 | |
2015-02-24 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 5 000 | 9 687 | 106,68 | 8,43 | 42 150 | 81 661 | |
2015-02-02 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −365 | 3 291 | −9,98 | ||||
2015-02-02 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −138 | 4 687 | −2,86 | 54,09 | −7 464 | 253 520 | |
2015-02-02 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 365 | 4 825 | 8,18 | ||||
2015-01-27 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −302 | 302 | −50,00 | ||||
2015-01-27 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −114 | 4 460 | −2,49 | 55,02 | −6 272 | 245 389 | |
2015-01-27 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 302 | 4 574 | 7,07 | ||||
2015-01-27 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −338 | 1 693 | −16,64 | ||||
2015-01-27 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −128 | 4 272 | −2,91 | 55,02 | −7 043 | 235 045 | |
2015-01-27 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 338 | 4 400 | 8,32 | ||||
2015-01-14 |
|
4 | CPHD |
CEPHEID
Non-qualified option (right to buy) |
M - Exercise | X | −5 000 | 5 000 | −50,00 | |||
2015-01-14 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 4 062 | −55,18 | 56,90 | −284 500 | 231 128 |
2015-01-14 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 5 000 | 9 062 | 123,09 | 8,43 | 42 150 | 76 393 |
2014-12-02 |
|
4 | CPHD |
CEPHEID
Non-qualified option (right to buy) |
M - Exercise | X | −15 000 | 10 000 | −60,00 | |||
2014-12-02 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 4 062 | −55,18 | 56,34 | −281 700 | 228 853 |
2014-12-02 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 9 062 | −35,56 | 55,78 | −278 900 | 505 478 |
2014-12-02 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 14 062 | −26,23 | 55,23 | −276 150 | 776 644 |
2014-12-02 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 15 000 | 19 062 | 369,28 | 8,43 | 126 450 | 160 693 |
2014-12-01 |
|
4 | CPHD |
CEPHEID
Non-qualified option (right to buy) |
M - Exercise | −75 000 | 0 | −100,00 | ||||
2014-12-01 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | −75 000 | 4 062 | −94,86 | 54,62 | −4 096 222 | 221 851 | |
2014-12-01 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 75 000 | 79 062 | 1 846,38 | 19,85 | 1 488 750 | 1 569 381 | |
2014-11-17 |
|
4 | CPHD |
CEPHEID
Non-qualified option (right to buy) |
M - Exercise | X | −5 000 | 25 000 | −16,67 | |||
2014-11-17 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 4 062 | −55,18 | 54,68 | −273 400 | 222 110 |
2014-11-17 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 5 000 | 9 062 | 123,09 | 8,43 | 42 150 | 76 393 |
2014-10-31 |
|
4 | CPHD |
CEPHEID
Non-qualified option (right to buy) |
M - Exercise | X | −5 000 | 30 000 | −14,29 | |||
2014-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 4 062 | −55,18 | 54,14 | −270 700 | 219 917 |
2014-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 5 000 | 9 062 | 123,09 | 8,43 | 42 150 | 76 393 |
2014-10-31 |
|
4 | CPHD |
CEPHEID
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 35 000 | −30,00 | |||
2014-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 4 062 | −55,18 | 53,60 | −268 000 | 217 723 |
2014-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 9 062 | −35,56 | 53,07 | −265 350 | 480 920 |
2014-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 14 062 | −26,23 | 52,55 | −262 750 | 738 958 |
2014-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 15 000 | 19 062 | 369,28 | 8,43 | 126 450 | 160 693 |
2014-10-31 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −366 | 3 656 | −9,10 | ||||
2014-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −138 | 4 062 | −3,29 | 51,90 | −7 162 | 210 818 | |
2014-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 366 | 4 200 | 9,55 | ||||
2014-10-28 |
|
4 | CPHD |
CEPHEID
Non-qualified option (right to buy) |
M - Exercise | X | −5 000 | 50 000 | −9,09 | |||
2014-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 3 834 | −56,60 | 52,03 | −260 150 | 199 483 |
2014-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 5 000 | 8 834 | 130,41 | 8,43 | 42 150 | 74 471 |
2014-10-28 |
|
4 | CPHD |
CEPHEID
Non-qualified option (right to buy) |
M - Exercise | X | −10 000 | 55 000 | −15,38 | |||
2014-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 3 834 | −56,60 | 51,51 | −257 550 | 197 489 |
2014-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 8 834 | −36,14 | 51,00 | −255 000 | 450 534 |
2014-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 10 000 | 13 834 | 260,82 | 8,43 | 84 300 | 116 621 |
2014-10-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −302 | 604 | −33,33 | ||||
2014-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −114 | 3 834 | −2,89 | 50,08 | −5 709 | 192 007 | |
2014-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 302 | 3 948 | 8,28 | ||||
2014-10-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −339 | 2 031 | −14,30 | ||||
2014-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −128 | 3 646 | −3,39 | 50,08 | −6 410 | 182 592 | |
2014-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 339 | 3 774 | 9,87 | ||||
2014-07-31 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −365 | 4 022 | −8,32 | ||||
2014-07-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −138 | 3 340 | −3,97 | 39,50 | −5 451 | 131 930 | |
2014-07-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 365 | 3 478 | 11,73 | ||||
2014-07-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −302 | 906 | −25,00 | ||||
2014-07-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −114 | 3 113 | −3,53 | 39,47 | −4 500 | 122 870 | |
2014-07-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 302 | 3 227 | 10,32 | ||||
2014-07-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −338 | 2 370 | −12,48 | ||||
2014-07-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −128 | 2 925 | −4,19 | 40,55 | −5 190 | 118 609 | |
2014-07-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 338 | 3 053 | 12,45 | ||||
2014-04-30 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −1 463 | 4 387 | −25,01 | ||||
2014-04-30 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −339 | 0 | −100,00 | ||||
2014-04-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −550 | 2 715 | −16,85 | 42,14 | −23 177 | 114 410 | |
2014-04-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 463 | 3 265 | 81,19 | ||||
2014-04-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −128 | 1 802 | −6,63 | 42,14 | −5 394 | 75 936 | |
2014-04-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 339 | 1 930 | 21,31 | ||||
2014-04-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −302 | 1 208 | −20,00 | ||||
2014-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −114 | 1 591 | −6,69 | 42,02 | −4 790 | 66 854 | |
2014-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 302 | 1 705 | 21,53 | ||||
2014-04-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −339 | 2 708 | −11,13 | ||||
2014-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −128 | 1 403 | −8,36 | 43,55 | −5 574 | 61 101 | |
2014-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 339 | 1 531 | 28,44 | ||||
2014-04-23 |
|
4 | CPHD |
CEPHEID
Non-Qualified Stock Option (right to buy) |
A - Award | 41 250 | 41 250 | |||||
2014-04-23 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
A - Award | 4 500 | 4 500 | |||||
2014-01-30 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −338 | 339 | −49,93 | ||||
2014-01-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −149 | 1 192 | −11,11 | 46,56 | −6 937 | 55 500 | |
2014-01-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 338 | 1 341 | 33,70 | ||||
2014-01-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −302 | 1 510 | −16,67 | ||||
2014-01-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −133 | 1 003 | −11,71 | 48,11 | −6 399 | 48 254 | |
2014-01-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 302 | 1 136 | 36,21 | ||||
2014-01-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −338 | 3 047 | −9,99 | ||||
2014-01-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −149 | 834 | −15,16 | 48,11 | −7 168 | 40 124 | |
2014-01-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 338 | 983 | 52,40 | ||||
2013-11-18 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | −5 000 | 0 | −100,00 | |||
2013-11-18 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 645 | −88,57 | 42,18 | −210 900 | 27 206 |
2013-11-18 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 5 000 | 5 645 | 775,19 | 11,94 | 59 700 | 67 401 |
2013-11-13 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | −5 000 | 5 000 | −50,00 | |||
2013-11-13 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 645 | −88,57 | 41,76 | −208 800 | 26 935 |
2013-11-13 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 5 000 | 5 645 | 775,19 | 11,94 | 59 700 | 67 401 |
2013-10-30 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | −5 000 | 10 000 | −33,33 | |||
2013-10-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 645 | −88,57 | 41,35 | −206 750 | 26 671 |
2013-10-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 5 000 | 5 645 | 775,19 | 11,94 | 59 700 | 67 401 |
2013-10-30 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −339 | 677 | −33,37 | ||||
2013-10-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −177 | 645 | −21,53 | 40,91 | −7 241 | 26 387 | |
2013-10-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 339 | 822 | 70,19 | ||||
2013-10-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −302 | 1 812 | −14,29 | ||||
2013-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −158 | 483 | −24,65 | 40,48 | −6 396 | 19 552 | |
2013-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 302 | 641 | 89,09 | ||||
2013-10-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −339 | 3 385 | −9,10 | ||||
2013-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −177 | 339 | −34,30 | 40,26 | −7 126 | 13 648 | |
2013-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 339 | 516 | 191,53 | ||||
2013-10-22 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | −20 000 | 15 000 | −57,14 | |||
2013-10-22 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 177 | −96,58 | 40,94 | −204 700 | 7 246 |
2013-10-22 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 5 177 | −49,13 | 40,53 | −202 650 | 209 824 |
2013-10-22 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −10 000 | 10 177 | −49,56 | 40,45 | −404 500 | 411 660 |
2013-10-22 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 20 000 | 20 177 | 11 299,44 | 11,94 | 238 800 | 240 913 |
2013-09-19 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | −5 000 | 35 000 | −12,50 | |||
2013-09-19 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 177 | −96,58 | 39,34 | −196 700 | 6 963 |
2013-09-19 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 5 000 | 5 177 | 2 824,86 | 11,94 | 59 700 | 61 813 |
2013-09-18 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | −5 000 | 40 000 | −11,11 | |||
2013-09-18 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 177 | −96,58 | 38,95 | −194 750 | 6 894 |
2013-09-18 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 5 000 | 5 177 | 2 824,86 | 11,94 | 59 700 | 61 813 |
2013-09-09 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | −5 000 | 45 000 | −10,00 | |||
2013-09-09 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 177 | −96,58 | 38,56 | −192 800 | 6 825 |
2013-09-09 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 5 000 | 5 177 | 2 824,86 | 11,94 | 59 700 | 61 813 |
2013-09-09 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | −10 000 | 50 000 | −16,67 | |||
2013-09-09 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | −5 000 | 0 | −100,00 | |||
2013-09-09 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 177 | −96,58 | 38,18 | −190 900 | 6 758 |
2013-09-09 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 5 177 | −49,13 | 37,80 | −189 000 | 195 691 |
2013-09-09 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 10 177 | −32,94 | 37,43 | −187 150 | 380 925 |
2013-09-09 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 10 000 | 15 177 | 193,16 | 11,94 | 119 400 | 181 213 |
2013-09-09 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 5 000 | 5 177 | 2 824,86 | 7,35 | 36 750 | 38 051 |
2013-09-04 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | −5 129 | 177 | −96,66 | 36,62 | −187 824 | 6 482 | |
2013-07-30 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −338 | 1 016 | −24,96 | ||||
2013-07-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −128 | 5 293 | −2,36 | 34,44 | −4 408 | 182 291 | |
2013-07-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 338 | 5 421 | 6,65 | ||||
2013-07-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −302 | 2 114 | −12,50 | ||||
2013-07-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −114 | 5 083 | −2,19 | 34,53 | −3 936 | 175 516 | |
2013-07-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 302 | 5 197 | 6,17 | ||||
2013-07-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −338 | 3 724 | −8,32 | ||||
2013-07-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −128 | 4 895 | −2,55 | 33,80 | −4 326 | 165 451 | |
2013-07-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 338 | 5 023 | 7,21 | ||||
2013-05-01 |
|
4 | CPHD |
CEPHEID
Non-Qualified Stock Option (right to buy) |
A - Award | 52 500 | 52 500 | |||||
2013-05-01 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
A - Award | 5 850 | 5 850 | |||||
2013-05-01 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −339 | 1 354 | −20,02 | ||||
2013-05-01 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −128 | 4 685 | −2,66 | 38,66 | −4 948 | 181 122 | |
2013-05-01 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 339 | 4 813 | 7,58 | ||||
2013-04-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −302 | 2 416 | −11,11 | ||||
2013-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −114 | 4 474 | −2,48 | 38,42 | −4 380 | 171 891 | |
2013-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 302 | 4 588 | 7,05 | ||||
2013-04-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −1 355 | 4 062 | −25,01 | ||||
2013-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −510 | 4 286 | −10,63 | 37,95 | −19 354 | 162 654 | |
2013-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 355 | 4 796 | 39,38 | ||||
2013-02-25 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | −15 000 | 0 | −100,00 | ||||
2013-02-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | −15 000 | 3 441 | −81,34 | 36,13 | −541 994 | 124 333 | |
2013-02-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 15 000 | 18 441 | 435,92 | 7,38 | 110 700 | 136 095 | |
2013-01-30 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −338 | 1 693 | −16,64 | ||||
2013-01-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −149 | 3 359 | −4,25 | 36,09 | −5 377 | 121 226 | |
2013-01-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 338 | 3 508 | 10,66 | ||||
2013-01-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −302 | 2 718 | −10,00 | ||||
2013-01-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −133 | 3 170 | −4,03 | 37,83 | −5 031 | 119 921 | |
2013-01-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 302 | 3 303 | 10,06 | ||||
2012-10-31 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −339 | 2 031 | −14,30 | ||||
2012-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −159 | 3 001 | −5,03 | 30,46 | −4 843 | 91 410 | |
2012-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 339 | 3 160 | 12,02 | ||||
2012-10-29 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −302 | 3 020 | −9,09 | ||||
2012-10-29 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −141 | 2 821 | −4,76 | 31,10 | −4 385 | 87 733 | |
2012-10-29 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 302 | 2 962 | 11,35 | ||||
2012-07-31 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −338 | 2 370 | −12,48 | ||||
2012-07-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −158 | 2 578 | −5,77 | 32,93 | −5 203 | 84 894 | |
2012-07-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 338 | 2 736 | 14,10 | ||||
2012-07-26 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −302 | 3 322 | −8,33 | ||||
2012-07-26 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −141 | 2 398 | −5,55 | 32,51 | −4 584 | 77 959 | |
2012-07-26 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 302 | 2 539 | 13,50 | ||||
2012-07-03 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | −10 000 | 15 000 | −40,00 | |||
2012-07-03 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 2 237 | −69,09 | 45,69 | −228 450 | 102 209 |
2012-07-03 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 7 237 | −40,86 | 45,23 | −226 150 | 327 330 |
2012-07-03 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 10 000 | 12 237 | 447,03 | 7,38 | 73 800 | 90 309 |
2012-06-28 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | −5 000 | 25 000 | −16,67 | |||
2012-06-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 000 | 2 237 | −69,09 | 44,79 | −223 950 | 100 195 |
2012-06-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 5 000 | 7 237 | 223,51 | 7,38 | 36 900 | 53 409 |
2012-05-01 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −339 | 2 708 | −11,13 | ||||
2012-05-01 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −159 | 2 237 | −6,64 | 38,50 | −6 122 | 86 124 | |
2012-05-01 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 339 | 2 396 | 16,48 | ||||
2012-04-26 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −1 209 | 3 624 | −25,02 | ||||
2012-04-26 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −565 | 2 057 | −21,55 | 37,17 | −21 001 | 76 459 | |
2012-04-26 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 209 | 2 622 | 85,56 | ||||
2012-04-26 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
A - Award | 48 750 | 48 750 | |||||
2012-04-26 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
A - Award | 5 417 | 5 417 | |||||
2012-02-09 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | −20 000 | 30 000 | −40,00 | |||
2012-02-09 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | −26 750 | 5 000 | −84,25 | |||
2012-02-09 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −10 000 | 1 413 | −87,62 | 44,49 | −444 900 | 62 864 |
2012-02-09 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −400 | 11 413 | −3,39 | 44,43 | −17 770 | 507 034 |
2012-02-09 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −9 600 | 11 813 | −44,83 | 43,52 | −417 811 | 514 125 |
2012-02-09 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −26 750 | 21 413 | −55,54 | 43,06 | −1 151 882 | 922 065 |
2012-02-09 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 46 750 | 48 163 | 3 308,56 | 7,38 | 345 015 | 355 443 | |
2012-01-31 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −338 | 3 047 | −9,99 | ||||
2012-01-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −142 | 1 413 | −9,13 | 43,14 | −6 126 | 60 957 | |
2012-01-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 338 | 1 555 | 27,77 |